human monoclonal antibody

Biocon Biologics Gets Green Light to Launch Denosumab Biosimilars in Europe and Global Markets

Biocon Biologics Ltd (BBL), a fully integrated global biosimilars company and subsidiary of Biocon Ltd, has entered into a settlement…